The acceptability of prophylactic mastectomy among lay people and health professionals: A pilot study

Anderson, 1996 Anderson, 2001 Anderson, 2008 Anderson, 2019 Antoniou, 2003, Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies, American Journal of Human Genetics, 72, 1117, 10.1086/375033 Baize, 2008, Féminité et cancer du sein, approche particulière de l’annonce en cancérologie, Bulletin du cancer, 95, 9 Brandberg, 2008, Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: A prospective 1-year follow-up study, Journal of Clinical Oncology, 26, 3943, 10.1200/JCO.2007.13.9568 Bray, 2018, Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Carlson, 2012, Metastatic breast cancer, featured updates to the NCCN Guidelines, Journal of the National Comprehensive Cancer Network, 10, 821, 10.6004/jnccn.2012.0086 Claes, 2005, Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer, Behavioral Medicine, 31, 93, 10.3200/BMED.31.3.93-106 Covelli, 2014, Increasing mastectomy rates-the effect of environmental factors on the choice for mastectomy: A comparative analysis between Canada and the United States, Annals of Surgical Oncology, 21, 3173, 10.1245/s10434-014-3955-4 De Leeuw, 2008, Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer, Familial Cancer, 7, 347, 10.1007/s10689-008-9189-5 Den Heijer, 2012, Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up study, European Journal of Cancer, 48, 1263, 10.1016/j.ejca.2011.10.020 Delvaux, 2006, L’expérience du cancer pour les familles, Cahiers critiques de thérapie familiale et de pratiques de réseaux, 36, 81, 10.3917/ctf.036.101 Eisinger, 2010, Oncogénétique : prédire et agir, 550 Eisinger, 2004, Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l’ovaire, Bulletin du Cancer, 91, 219 Evans, 2014, The Angelina Jolie effect: How high celebrity profile can have a major impact on provision of cancer related services, Breast Cancer Research, 16, 442, 10.1186/s13058-014-0442-6 Friebel, 2007, Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers, Clinical Breast Cancer, 7, 875, 10.3816/CBC.2007.n.053 Gopie, 2013, Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer, Familial Cancer, 12, 479, 10.1007/s10689-012-9588-5 Gros, 2009 Guedj, 2006, Under what conditions is the breaking of confidentiality acceptable to lay people and health professionals?, Journal of Medical Ethics, 32, 414, 10.1136/jme.2005.012195 Hallowell, 2012, Looking different, feeling different: Women's reactions to risk-reducing breast and ovarian surgery, Familial Cancer, 11, 215, 10.1007/s10689-011-9504-4 Haroun, 2011, Reasons for riskreducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer, Breast, 20, 254, 10.1016/j.breast.2011.01.006 Hartmann, 1999, Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer, The New England Journal of Medicine, 340, 77, 10.1056/NEJM199901143400201 2014 Heiniger, 2015, Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer, Familial Cancer, 14, 105, 10.1007/s10689-014-9759-7 Houn, 1995, The practice of prophylactic mastectomy: A survey of Maryland surgeons, American Journal of Public Health, 85, 801, 10.2105/AJPH.85.6.801 Howard, 2009, Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: A systematic review, Journal of Genetic Counseling, 18, 578, 10.1007/s10897-009-9245-9 Howard, 2011, Preserving the self: The process of decision making about hereditary breast cancer and ovarian cancer risk reduction, Qualitive Health Research, 21, 502, 10.1177/1049732310387798 2009 2017 2019 Isern, 2008, Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction, Journal of Plastic, Reconstructive & Aesthetic Surgery, 61, 1177, 10.1016/j.bjps.2007.08.006 Julian-Reynier, 2000, Physicians’ attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines, European Journal of Human Genetic, 8, 204, 10.1038/sj.ejhg.5200418 Kaya, 2013, Breast reconstruction, Experimental Oncology, 35, 280 Lalloo, 2000, A protocol for preventive mastectomy in women with an increased lifetime risk of breast cancer, European Journal of Surgical Oncology, 26, 711, 10.1053/ejso.2000.0986 McQuirter, 2010, Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy, Oncology Nursing Forum, 37, 313, 10.1188/10.ONF.313-320 Metcalfe, 2008, International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers, International Journal of Cancer, 122, 2017, 10.1002/ijc.23340 Mullet, 2000, Developmental and Cognitive Points of View on Forgiveness, 111 Mullet, 2012, Functional measurement in the field of empirical bioethics, Psicológica, 33, 665 Mullet, 2021 Padamsee, 2017, Decision making for breast cancer prevention among women at elevated risk, Breast Cancer Research, 19, 34, 10.1186/s13058-017-0826-5 Razavi, 2002 Razavi, 2008 Reich, 2009, Cancer et image du corps : identité, représentation et symbolique : travail présenté lors des 27es Journées de la Société de l’Information Psychiatrique, Lille 24–27 septembre 2008, L’information psychiatrique, 85, 247, 10.3917/inpsy.8503.0247 Rosman, 2004, Cancer and stigma: Experience of patients with chemotherapy-induced alopecia, Patient Education and Counseling, 52, 333, 10.1016/S0738-3991(03)00040-5 Skytte, 2010, Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: Uptake and timing, Clinical Genetics, 77, 342, 10.1111/j.1399-0004.2009.01329.x Tan, 2009, Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy, Hereditary Cancer in Clinical Practice, 7, 6, 10.1186/1897-4287-7-6 Tsaras, 2018, Assessment of depression and anxiety in breast cancer patients: Prevalence and associated factors, Asian Pac J Cancer Prev, 19, 1661 Underhill, 2013, Seeking balance: Decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation, Journal of Genetics Counseling, 23, 350, 10.1007/s10897-013-9667-2 Van Dijk, 2008, Decision making regarding prophylactic mastectomy: Stability of preferences and the impact of anticipated feelings of regret, Journal of Clinical Oncology, 26, 2358, 10.1200/JCO.2006.10.5494